The National Heart, Lung, and Blood Institute (NHLBI) would like to inform physicians and researchers of two new and exciting funding opportunities upcoming in 2020. NHLBI has released the following “Notices of Intent” to provide interested parties advanced word of these significant awards. Follow the links below to learn more.

Notice of Intent to Publish a Funding Opportunity Announcement for Generate A Precision Medicine Intergenerational Resource for the Study of Factor VIII Immunogenicity in Severe Hemophilia A: Clinical Coordinating Center.

Notice of Intent to Publish a Funding Opportunity Announcement for Generate an Intergenerational Precision Medicine Resource for the Study of Factor VIII Immunogenicity in Severe Hemophilia A: Biospecimen and Data Resource Center (U24).

The estimated publication date of the official funding opportunity announcement for both awards is March 2, 2020. Please direct all requests for information to: [email protected].

Recent News

Medical
Survey
Take the HTC Patient Satisfaction Survey
Medical
Rebinyn Supplies Restored in 3,000 IU Vial Size
Medical
Hemophilia B Therapy FDA Approved for Expanded Indication
Medical
Nurses standing together
Video Celebrates Nurses in Bleeding Disorders Care